Medical Device Product Liability and Insurance: A Complete Guide for Manufacturers
Everything medical device manufacturers need to know about product liability — strict liability vs negligence, insurance coverage types, EU Directive 2024/2853 changes, recall coverage, and risk mitigation strategies for 2026 and beyond.
Why Product Liability Keeps Medical Device Executives Awake at Night
Billions of dollars are paid out each year as a result of medical lawsuits, and these lawsuits do not just target doctors and hospitals. They name every entity in the chain of distribution — manufacturers, distributors, contract manufacturers, importers, and even software developers. The FDA reported approximately 14,500 annual reports of serious injury or death from defective medical devices over the last two decades. Product liability verdicts averaged $7 million in jury trials, with the top 10 product liability class actions reaching $17.9 billion in settlements in 2025 alone.
For medical device manufacturers, product liability is not a theoretical risk. It is an operational certainty that must be managed through quality systems, legal strategy, and insurance. The medical device liability insurance market has been growing steadily, driven by both the expanding device market and the increasing severity of claims. Industry analysts project continued growth through the decade as connected devices, AI-enabled products, and expanded EU liability rules increase manufacturer exposure.
This guide covers the legal foundations of product liability, the types of claims device manufacturers face, insurance coverage options, the EU's new product liability directive taking effect in December 2026, and practical strategies for reducing liability exposure.
The Legal Foundations of Product Liability
Product liability law holds manufacturers, distributors, and sellers responsible for injuries caused by defective products. In the United States, product liability is primarily governed by state law, though federal regulations (particularly FDA requirements) significantly influence the legal landscape. Plaintiffs can bring claims under several legal theories, often simultaneously.
Strict Liability
Under strict liability, a plaintiff does not need to prove the manufacturer was negligent or at fault. They must prove three elements:
- The defendant manufactured or sold the product
- The product was defective when it left the defendant's possession
- The defect caused the plaintiff's injuries
Strict liability is the most dangerous theory for manufacturers because it eliminates the need to show that the manufacturer knew about the defect or could have prevented it. The mere existence of a defect that caused harm is sufficient. Most states follow the Restatement (Second) of Torts Section 402A or the Restatement (Third) of Torts: Products Liability for strict liability claims.
Negligence
Under negligence, a plaintiff must prove that the manufacturer failed to exercise reasonable care and that this failure caused the injury. This requires showing:
- The manufacturer owed a duty of care to the plaintiff
- The manufacturer breached that duty (e.g., by failing to test adequately, ignoring known risks, or cutting corners in manufacturing)
- The breach directly caused the plaintiff's injury
- The plaintiff suffered actual damages
Negligence claims allow defendants to argue that they met the applicable standard of care — a defense not available under strict liability.
Breach of Warranty
Warranty claims arise when a product fails to perform as promised. These can be:
- Express warranty: The manufacturer made specific claims about the product's safety or performance that turned out to be false
- Implied warranty of merchantability: The product is not fit for its ordinary purpose
- Implied warranty of fitness for a particular purpose: The product fails to meet the specific needs the manufacturer knew the buyer had
Failure to Warn
Failure-to-warn claims are a subset of product liability that focuses specifically on the adequacy of warnings and instructions. The manufacturer can be held liable if:
- Known risks were not disclosed in labeling or instructions for use
- Warnings were present but insufficiently prominent or clear
- The manufacturer failed to update warnings when new risks became known post-market
For medical devices, failure-to-warn claims are particularly common because the manufacturer's instructions for use (IFU) serve as the primary communication channel to physicians and patients about proper use and known risks.
The Three Types of Product Defects
Design Defects
A design defect exists when the entire product line is inherently dangerous due to its design — meaning every unit produced has the same risk. The plaintiff argues that a safer alternative design was feasible and should have been used.
Medical device example: A hip implant designed with a stem angle that causes excessive wear debris in all implanted units, leading to tissue damage and implant failure regardless of manufacturing quality.
Defense strategies:
- Demonstrate that the design met the state of the art at the time of design
- Show that the risk-utility balance favored the chosen design
- Present evidence of FDA review and clearance/approval of the design
Manufacturing Defects
A manufacturing defect occurs when a specific unit or batch deviates from the intended design due to errors in production. Unlike design defects, most units are not affected — only the defective ones.
Medical device example: A batch of surgical staplers produced with misaligned components due to a calibration error, causing the staples to deform during firing in a subset of units.
Defense strategies:
- Demonstrate robust quality control processes (ISO 13485, 21 CFR 820/QMSR)
- Show that the manufacturing process was validated and monitored
- Present traceability records proving the specific unit met specifications
Marketing Defects (Failure to Warn)
A marketing defect involves inadequate warnings, instructions, or representations about the product's risks. This applies even if the product is well-designed and properly manufactured.
Medical device example: An implantable device where the IFU does not warn about a known risk of interaction with MRI scans, and a patient is injured during an MRI.
Defense strategies:
- Demonstrate that warnings met FDA labeling requirements
- Show that the learned intermediary doctrine applies (the physician was adequately informed and made the decision for the patient)
- Present evidence that the physician was aware of the risk through other channels
Major Medical Device Litigation Cases
Understanding the scale and nature of device litigation helps manufacturers calibrate their risk management and insurance strategies.
Active Mass Torts (as of February 2026)
| Litigation | Pending Cases | Settlement Value |
|---|---|---|
| Talcum Powder (J&J) | 67,300+ cases | Largest active mass tort |
| Hernia Mesh (C.R. Bard) | 24,000+ cases | Over $1 billion in settlements |
| Roundup (Bayer/Monsanto) | 4,511 MDL cases; 100,000+ total | $2.1 billion verdict in 2025 |
| Social Media (Meta/TikTok/Snap) | 4,414 cases | Ongoing MDL |
| GLP-1 Drugs (Ozempic/Wegovy) | Emerging MDL | Bellwether trials expected 2026 |
Source: Judicial Panel on Multidistrict Litigation (JPML), February 2026.
Key Statistics
- About 67% of product liability cases end in plaintiff settlements
- Average case duration: 1–3 years
- Product liability verdicts averaged $7 million in jury trials
- Settlements before trial range between $10,000 and $500,000
- Total settlements: Top 10 product liability class actions reached $17.9 billion in 2025
- Over 197,000 pending cases in product liability multidistrict litigations as of February 2026
Insurance Coverage for Medical Device Manufacturers
Product Liability Insurance
This is the core coverage. Product liability insurance covers claims of bodily injury or property damage caused by a defective product. Key features:
- Occurrence-based coverage: Covers claims arising from incidents that occurred during the policy period, regardless of when the claim is filed. This is critical for medical devices, where injuries may not manifest for years.
- Claims-made coverage: Covers only claims filed during the policy period. Less desirable for device manufacturers due to the long latency of many device-related injuries.
- Typical limits: $1 million per occurrence / $2 million aggregate for small manufacturers. Larger companies may carry $5–10 million or more per occurrence, with excess/umbrella layers above.
Premiums start around $2,298 per year for small medical equipment manufacturers but vary significantly based on device classification, claims history, and coverage limits.
General Liability Insurance
Commercial general liability (CGL) policies cover third-party bodily injury and property damage that occurs on business premises or as a result of business operations. For device manufacturers, CGL provides a baseline but does not specifically address product defects — product liability coverage fills that gap.
Professional Liability / Errors and Omissions
E&O coverage addresses claims of financial damage resulting from professional mistakes. For device companies, this can cover claims that a device failed to perform to specification without causing physical injury — for example, a diagnostic device that produces incorrect results leading to unnecessary treatment.
Product Recall Insurance
Standard product liability policies typically exclude the costs of recalling a defective product. Recall insurance covers:
- Notification costs (contacting customers, hospitals, distributors)
- Transportation and disposal of recalled products
- Replacement product costs
- Business interruption losses during the recall period
- Reputation management expenses
This coverage is increasingly important as FDA's recall authority and expectations have grown.
Clinical Trial Liability Insurance
For companies conducting clinical investigations, clinical trial liability insurance covers claims from trial participants who suffer injury during the study. Many institutional review boards (IRBs) and clinical sites require proof of this coverage before allowing a trial to proceed.
Cyber Liability Insurance
Connected medical devices and SaMD products that collect, transmit, or store patient data face cybersecurity risks. Cyber liability insurance covers:
- Data breach notification costs
- Regulatory fines and penalties
- Business interruption from cyberattacks
- Ransomware payments
- Third-party liability for compromised patient data
EU Product Liability Directive 2024/2853: What Changes in December 2026
The EU is implementing a fundamentally modernized product liability regime through Directive (EU) 2024/2853, which takes effect on December 9, 2026. This directive represents the most significant change to EU product liability law in decades and has major implications for medical device manufacturers.
Key Changes
Expanded definition of "product": The directive explicitly includes software, AI systems, digital design files, and connected services essential to product safety. This means standalone SaMD and AI-enabled devices are now directly subject to strict liability.
Manufacturer liability for updates: Manufacturers will be liable for harmful consequences resulting from software updates and upgrades, as well as for failing to provide necessary safety updates. This creates ongoing liability exposure throughout the product lifecycle.
Non-EU manufacturers must have EU representatives: Companies outside the EU will require an accessible EU representative, robust supply-chain contracts, and comprehensive compliance structures to maintain EU market access.
Abolished liability cap: The previous statutory liability cap has been entirely removed, meaning there is no upper limit on damages that can be awarded.
Evidence rules favor claimants: Disclosure obligations shift in favor of claimants, making it easier for plaintiffs to obtain internal manufacturer documents during litigation.
Refurbishers can become manufacturers: Entities that substantially modify or refurbish products can be classified as new manufacturers under the law, assuming the same liability as the original manufacturer.
What Device Companies Should Do Now
- Review product liability insurance limits against the uncapped exposure in the EU market
- Map all software and AI components in your device portfolio — these are now directly subject to strict liability
- Implement a post-market software update policy that documents risk assessments for every update
- Establish EU representative arrangements if selling from outside the EU
- Review supply chain contracts for indemnification provisions that address the new liability landscape
- Train quality and regulatory teams on the new requirements before December 2026
How FDA Classification Affects Liability and Insurance
| FDA Classification | Risk Level | Typical Claims Frequency | Insurance Implications |
|---|---|---|---|
| Class I | Low | Few claims, typically minor | Lower premiums, standard coverage |
| Class II | Moderate | Moderate claims volume, some high-severity | Higher premiums, may require specialized underwriting |
| Class III | High | Fewer claims but very high severity | Significant premiums, many insurers exclude Class III; coverage may be limited or require excess layers |
Some insurers, including Admiral Insurance Group, explicitly limit medical device liability coverage to Class I and Class II devices, excluding implantable and life-sustaining equipment. Class III manufacturers typically need to work with specialty insurers or Lloyd's syndicates.
Statutes of Limitation: The Long Tail of Device Liability
Statutes of limitation for product liability claims vary by state, typically ranging from 2 to 6 years from the date of injury discovery. Some jurisdictions allow claims for many years if injuries were not immediately apparent — a common situation with implantable devices.
This extended exposure is why occurrence-based coverage is critical for device manufacturers. An occurrence-based policy from 2018 covers claims filed in 2026 from an incident that occurred during the 2018 policy period. Claims-made policies would require continuous renewal or tail coverage to achieve the same protection.
For international sales, statutes of limitation may differ significantly from US law. Companies selling into the EU should note that the new directive's abolishment of liability caps, combined with European limitation periods, creates exposure that may exceed US levels for the same device.
Risk Mitigation Strategies
Design-Phase Risk Reduction
- Apply ISO 14971 risk management throughout design controls
- Conduct formal design reviews with risk analysis at each gate
- Document all design decisions and the rationale behind them (defensibility)
- Implement human factors engineering to reduce use errors
Manufacturing Quality
- Maintain ISO 13485 certification and FDA QMSR compliance
- Validate all manufacturing processes per 21 CFR 820 (or QMSR effective February 2026)
- Implement robust incoming inspection and supplier quality management
- Maintain complete traceability from raw materials to finished device
Post-Market Vigilance
- Monitor complaint trends through a documented complaint handling process
- File Medical Device Reports (MDRs) within FDA-required timeframes
- Conduct periodic post-market surveillance reviews per EU MDR Article 84
- Update risk management files when new hazard information emerges
- Issue field safety notices and implement recalls promptly when warranted
Contractual Protections
- Include indemnification provisions in all distribution and supply agreements
- Require additional insured status from contract manufacturers and component suppliers
- Align insurance requirements with contractual liability allocation
- Include warranty disclaimers and limitation of liability clauses where permitted by law
Documentation for Defensibility
- Maintain a complete Design History File (DHF) for every device
- Document all risk analyses, including risks that were accepted and the rationale
- Keep detailed records of all labeling decisions, including warnings that were considered but not included
- Preserve all communications with FDA (submissions, feedback, meeting minutes)
How to Choose the Right Insurance
Step 1: Assess Your Risk Profile
- What FDA classification are your devices?
- Do you manufacture implantable devices?
- Do you sell internationally (especially the EU)?
- Do you have connected devices or SaMD products?
- What is your claims history?
Step 2: Determine Coverage Types Needed
| Coverage | Who Needs It |
|---|---|
| Product liability | Every device manufacturer |
| General liability | Every company |
| Product recall | Manufacturers of moderate to high-risk devices |
| Clinical trial liability | Companies conducting clinical investigations |
| Cyber liability | Connected device and SaMD manufacturers |
| Professional E&O | Diagnostic and decision-support device companies |
| D&O (Directors and Officers) | Companies with a board of directors |
Step 3: Select Coverage Limits
Minimum recommended limits by company stage:
| Company Stage | Per-Occurrence | Aggregate | Additional |
|---|---|---|---|
| Pre-revenue / startup | $1M | $2M | Umbrella if investors require |
| Revenue-generating, Class I/II | $2M | $5M | Recall coverage |
| Established, Class II/III | $5M–$10M | $10M–$25M | Excess layers, recall, cyber |
| Multinational | $10M+ | $25M+ | Local policies for EU, excess/umbrella |
Step 4: Find the Right Insurer
Major insurers in the medical device liability space include AIG, Chubb, Zurich, AXA, Allianz, CNA, Travelers, and specialty underwriters at Lloyd's. Work with a broker who specializes in life sciences and understands the regulatory landscape — a broker who handles only general manufacturing insurance will not adequately represent your risk profile.
Key Takeaways
- Product liability is an operational reality for every medical device manufacturer. It cannot be eliminated, only managed.
- Strict liability means you can be held responsible even without fault. This makes insurance non-negotiable.
- The EU's new product liability directive (December 2026) fundamentally expands liability to include software, AI, updates, and connected services — with no cap on damages.
- Occurrence-based coverage is essential for the long-tail nature of device claims. Claims-made coverage may leave gaps for injuries that manifest years later.
- Insurance is one layer; quality systems are the foundation. The best liability strategy is preventing defects through rigorous design controls, manufacturing quality, and post-market surveillance.
- Class III devices face the toughest insurance market. Many standard insurers exclude them, requiring specialty coverage at significantly higher premiums.
- Document everything for defensibility. In litigation, the manufacturer with the most complete records usually prevails.